NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 318 filers reported holding NATERA INC in Q3 2023. The put-call ratio across all filers is 1.90 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $15,105,490 | +136.6% | 341,367 | +432.1% | 0.05% | +165.0% |
| Q4 2020 | $6,384,000 | -46.0% | 64,150 | -60.8% | 0.02% | -53.5% |
| Q3 2020 | $11,818,000 | -31.8% | 163,600 | -52.9% | 0.04% | +26.5% |
| Q2 2020 | $17,318,000 | +162.6% | 347,342 | +57.3% | 0.03% | +112.5% |
| Q1 2020 | $6,594,000 | -11.9% | 220,822 | -0.6% | 0.02% | +6.7% |
| Q4 2019 | $7,484,000 | -32.0% | 222,160 | -33.8% | 0.02% | -31.8% |
| Q3 2019 | $11,002,000 | +18.9% | 335,430 | 0.0% | 0.02% | +22.2% |
| Q2 2019 | $9,252,000 | – | 335,430 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 797,436 | $35,286,543 | 33.31% |
| Kynam Capital Management, LP | 3,003,668 | $132,912,309 | 21.74% |
| Eversept Partners, LP | 2,492,636 | $110,299,143 | 9.33% |
| Sofinnova Investments, Inc. | 3,100,560 | $137,199,780 | 8.66% |
| Eagle Health Investments LP | 595,694 | $26,359,460 | 5.81% |
| BEACONLIGHT CAPITAL, LLC | 259,865 | $11,499,026 | 4.97% |
| Lagoda Investment Management, L.P. | 165,465 | $7,321,826 | 4.81% |
| Tri Locum Partners LP | 274,795 | $12,159,679 | 3.89% |
| Bain Capital Life Sciences Investors, LLC | 700,197 | $30,983,717 | 3.46% |
| SAMLYN CAPITAL, LLC | 4,400,226 | $194,710,000 | 3.18% |